Skip to content

Clinical trials

Observational Carcinoma, Non-Small-Cell Lung trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Observational Country / region: Austria Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20163
20172
20191
20201
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Hoffmann-La Roche2
Arbeitsgemeinschaft medikamentoese Tumortherapie1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
Janssen Research & Development, LLC1
Martin-Luther-Universität Halle-Wittenberg1
Medical University Innsbruck1
Medical University of Vienna1
Pierre Fabre Pharma GmbH1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung13
Lung Neoplasms3
Small Cell Lung Carcinoma2
Breast Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Renal Cell1
Carcinoma, Transitional Cell1
Colorectal Neoplasms1
Disease1
Liver Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.